FineMark National Bank & Trust Has $1.07 Million Stock Holdings in HCA Healthcare, Inc. (NYSE:HCA)

FineMark National Bank & Trust lessened its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 1.2% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 3,555 shares of the company’s stock after selling 42 shares during the quarter. FineMark National Bank & Trust’s holdings in HCA Healthcare were worth $1,067,000 at the end of the most recent reporting period.

Several other hedge funds also recently modified their holdings of HCA. Legacy Investment Solutions LLC acquired a new position in HCA Healthcare during the third quarter worth $39,000. Whipplewood Advisors LLC bought a new position in shares of HCA Healthcare in the 4th quarter valued at approximately $31,000. Tidemark LLC bought a new stake in HCA Healthcare during the fourth quarter worth approximately $36,000. Activest Wealth Management lifted its stake in shares of HCA Healthcare by 1,250.0% in the fourth quarter. Activest Wealth Management now owns 135 shares of the company’s stock worth $40,000 after buying an additional 125 shares during the last quarter. Finally, Pinnacle Bancorp Inc. grew its stake in HCA Healthcare by 50.0% in the 4th quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company’s stock valued at $45,000 after buying an additional 50 shares during the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

Insiders Place Their Bets

In other HCA Healthcare news, SVP Jennifer Berres sold 9,533 shares of the company’s stock in a transaction dated Friday, February 14th. The shares were sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the transaction, the senior vice president now directly owns 15,412 shares in the company, valued at approximately $4,971,757.08. This represents a 38.22 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 1.60% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts have recently issued reports on the company. KeyCorp lowered their price target on HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 7th. JPMorgan Chase & Co. reissued a “neutral” rating and issued a $380.00 price objective on shares of HCA Healthcare in a research report on Tuesday, December 17th. Cantor Fitzgerald reiterated an “overweight” rating and set a $405.00 target price on shares of HCA Healthcare in a research note on Monday, January 27th. Barclays dropped their price objective on shares of HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating on the stock in a report on Monday, January 27th. Finally, Morgan Stanley lowered their price target on HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating on the stock in a research note on Tuesday, December 17th. One analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat, HCA Healthcare currently has a consensus rating of “Moderate Buy” and a consensus target price of $385.67.

HCA Healthcare Price Performance

NYSE:HCA opened at $336.12 on Wednesday. HCA Healthcare, Inc. has a 12 month low of $289.98 and a 12 month high of $417.14. The company’s 50-day moving average price is $322.63 and its two-hundred day moving average price is $341.89. The company has a quick ratio of 0.97, a current ratio of 1.08 and a debt-to-equity ratio of 69.07. The firm has a market cap of $82.75 billion, a PE ratio of 15.30, a price-to-earnings-growth ratio of 1.10 and a beta of 1.68.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Friday, January 24th. The company reported $6.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same period in the prior year, the business posted $5.90 earnings per share. On average, equities analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, March 31st. Investors of record on Monday, March 17th will be issued a $0.72 dividend. The ex-dividend date is Monday, March 17th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.86%. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.66. HCA Healthcare’s dividend payout ratio (DPR) is currently 13.11%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.